Form4insider filings, from the source

SEC Form 4 · accession 0000921895-17-000024

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeffrey E. Eberwein
Director · 10% Owner
Period of report
Dec 30, 2016
Accepted (ET)
Jan 4, 2017 · 4:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F4Dec 30, 2016P40$6.51A69,911IBy: Separately Managed Account
9.00% Series A Cumulative Preferred StockF5,F2Dec 30, 2016J363,611$50.00A363,611IBy: Lone Star Value Investors, LP
Common StockF1,F2holding———1,666,755IBy: Lone Star Value Investors, LP

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
5% Convertible Note due May 2017F2$1.80Dec 30, 2016J—DMay 26, 2015May 26, 2019Common Stock2,777,7780I

Explanation of responses